Trial Profile
Phase 1 clinical trial of MOL4239 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jun 2017
Price :
$35
*
At a glance
- Drugs WP 1220 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 19 Jun 2017 New trial record